Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer has extremely high risk of relapse due to the lack of targeted therapies, intra- and inter-tumoral heterogeneity, and the inherent and acquired resistance to therapies. In this study, we evaluate the potential of prostate-specific membrane antigen (PSMA) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgenroth, Agnieszka, Tinkir, Ebru, Vogg, Andreas T. J., Sankaranarayanan, Ramya Ambur, Baazaoui, Fatima, Mottaghy, Felix M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805467/
https://www.ncbi.nlm.nih.gov/pubmed/31640747
http://dx.doi.org/10.1186/s13058-019-1205-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805467/
https://www.ncbi.nlm.nih.gov/pubmed/31640747
http://dx.doi.org/10.1186/s13058-019-1205-1

Ejemplares similares